Clinical Report: Design and Data Gathering Techniques in the Rheumatology Registry
Overview
The establishment of the Rheumatry registry in Iran aims to collect standardized data on rheumatic diseases, addressing a significant gap in real-world evidence in the region. This initiative is crucial for informing health policy and improving clinical care for patients with conditions like rheumatoid arthritis and systemic lupus erythematosus.
Background
Disease registries play a vital role in modern healthcare by systematically collecting data that informs clinical care, public health policy, and research. In rheumatology, registries enhance understanding of treatment effectiveness and safety, particularly for biologic agents. However, there is a notable deficit of such registries in low- and middle-income regions, including the Middle East, which hampers the ability to generate region-specific real-world evidence.
Data Highlights
Replace with qualitative insights or context about the registry's data collection methods.
Key Findings
The Rheumatry registry was established in 2016 as Iran's first national registry for rheumatic diseases.
It aims to collect longitudinal data on disease patterns, treatment use, and long-term outcomes in Iranian patients.
The registry is governed by the Rheumatology Research Center at Tehran University and supported by Iran’s Ministry of Health.
Rheumatry's design aligns with best practices observed in established international registries like CORRONA and BSRBR.
Standardized data collection will facilitate research and improve clinical care for conditions such as RA and SLE.
Clinical Implications
The establishment of the Rheumatry registry provides a framework for collecting essential data that can inform treatment decisions and health policies in Iran. By capturing real-world evidence, it can enhance understanding of disease management and improve patient outcomes in rheumatic diseases.
Conclusion
Rheumatry represents a significant advancement in the collection of rheumatology data in Iran, addressing critical gaps in evidence and supporting better healthcare strategies. This initiative may serve as a model for similar efforts in other low- and middle-income countries.
